Article
p53β: a new prognostic marker for patients with clear-cell renal cell carcinoma from 5.3 years of median follow-up
11 Jan 2018
Abstract excerpt
We previously reported six different p53 isoforms in renal cell carcinoma (RCC). In the present study, influences of p53β on recurrence-free survival (RFS) and overall survival (OS) were evaluated. Patients diagnosed with RCC in our center were into this study. mRNA expressions of p53 isoforms (p53α, p53β, p53γ) in tumors were determined by RT-PCR and real-time PCR. Functional yeast-based assay was performed to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
